CompletedPhase 2NCT07182305
Treatment Trial of Alveolar Echinococcosis
Studying Alveolar echinococcosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ministry of Health, Kyrgyzstan
- Principal Investigator
- Gulnara Minbaeva, MDDepartment of disease prevention and sanitary - epidemiological surveillance, Ministry of Health of the Kyrgyz Republic
- Intervention
- Efficacy of albendazole for early stage intervention of alveolar echinococcosis(drug)
- Enrollment
- 194 enrolled
- Eligibility
- 10-70 years · All sexes
- Timeline
- 2017 – 2023
Study locations (1)
- Department of disease prevention and sanitary - epidemiological surveillance, Bishkek, Kyrgyzstan
Collaborators
University of Zurich
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07182305 on ClinicalTrials.govOther trials for Alveolar echinococcosis
Additional recruiting or active studies for the same condition.